首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Outcome of third renal allograft retransplants versus primary transplants from paired donors.
【24h】

Outcome of third renal allograft retransplants versus primary transplants from paired donors.

机译:与配对供体相比,第三次同种异体肾移植的结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Third kidney retransplants have technical and immunologic hurdles that may preclude success, which is of particular importance in the contemporary context of discrepancy between organ supply and demand. METHODS: The outcomes of third renal transplant recipients (TRTR) were compared with those receiving a first transplant from paired donor kidneys to assess transplant success and complication rates. The Ontario-based Trillium Gift of Life Network database was used to identify deceased donors (n=28) who donated one kidney to a TRTR and the mate kidney to a primary renal transplant recipient (PRTR) from June 1977 to August 2006. RESULTS: As anticipated, TRTR were sensitized versus PRTR based on % panel reactive antibodies (24%+/-34% vs. 7%+/-14%, P=0.03). Delayed graft function (46% vs. 22%, P=0.05) and biopsy-proven rejection episodes (50% vs. 29%, P=0.01) occurred more frequently with TRTR despite greater frequency of induction therapy (74% vs. 35%, P=0.004). However, 1- and 5-year patient survival were similar at 93%, 83% and 96%, 87% for TRTR and PRTR, respectively. Accordingly, 1- and 5-year allograft survival censored for mortality, were comparable at 78%, 66% and 78%, 75%. Renal function was similar in both groups. Bacterial infections (43% vs. 18%, P=0.001) and wound problems (28% vs. 11%, P=0.09) were the only postoperative complications to occur more frequently in the TRTR. CONCLUSION: We conclude that third renal transplantation should not be discouraged based on functional outcomes alone.
机译:背景:第三次肾脏移植存在技术和免疫学障碍,可能妨碍成功,这在器官供需矛盾的当代背景下尤为重要。方法:比较了第三次肾移植受者(TRTR)与从配对供体肾脏接受第一次移植的人的结局,以评估移植的成功率和并发症发生率。基于安大略省的Trillium生命礼品网络数据库,用于识别从1977年6月到2006年8月之间向TRTR捐献一个肾脏并向主要肾脏移植接受者(PRTR)捐献配对肾脏的死者(n = 28)。结果:如所预期的,基于%反应性抗体,TRTR相对于PRTR敏化(24%+ /-34%对7%+ /-14%,P = 0.03)。尽管诱导治疗的发生频率更高,但TRTR发生的移植物功能延迟(46%vs. 22%,P = 0.05)和活检证实的排斥反应发作(50%vs. 29%,P = 0.01)更常见(74%vs. 35)。 %,P = 0.004)。但是,TRTR和PRTR的1年和5年患者生存率分别相似,分别为93%,83%和96%,87%。因此,对死亡率进行检查的同种异体移植的1年和5年生存率分别为78%,66%和78%,75%。两组的肾功能相似。细菌感染(43%vs. 18%,P = 0.001)和伤口问题(28%vs. 11%,P = 0.09)是TRTR中唯一发生频率更高的术后并发症。结论:我们得出结论,不应该仅根据功能预后不建议进行第三次肾移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号